Dr. Chiara Foglieni was trained as a biologist in cardiac electrophysiology and completed postgraduate training in biotechnology. From 1991-1997, she was a research fellow at the Mario Negri Scientific Institute, then she moved to the IRCCS San Raffaele Hospital and Scientific Institute, where she is now a senior researcher. Her activity focuses on translational research in the field of molecular alterations in atherothrombosis and cardiac disorders such as hypertrophic cardiomyopathy. Specifically, she is interested in the role of vessel wall components and inflammation in modulating vascular/microvascular alterations and platelet activation at molecular level. Her laboratory also collaborates on studies on patients with heart failure requiring cardiac mechanical supports. Dr. Foglieni' laboratory has optimized/applied a variety of research tools, i.e. 2D/3D models for vascular tissue culture and cell biology; techniques for histology, confocal/electron microscopy; methods for protein biochemistry and molecular biology (mRNAs and noncoding RNAs); and for ex vivo imaging. Collaboration with The Scripps Research Institute in CA led to the optimization of a system for quantifying of tissue thrombogenicity. Thanks to ongoing research agreement with PoliMi, her team provides biological setup of in vitro functional models in technologically advanced bioreactors, contributing to development of a co-patented system and the creation of a startup, named TTOP technologies S.r.l.
Dr. Chiara Foglieni was trained as a biologist in cardiac electrophysiology and completed postgraduate training in biotechnology. From 1991-1997, she was a research fellow at the Mario Negri Scientific Institute, then she moved to the IRCCS San Raffaele Hospital and Scientific Institute, where she is now a senior researcher. Her activity focuses on translational research in the field of molecular alterations in atherothrombosis and cardiac disorders such as hypertrophic cardiomyopathy. Specifically, she is interested in the role of vessel wall components and inflammation in modulating vascular/microvascular alterations and platelet activation at molecular level. Her laboratory also collaborates on studies on patients with heart failure requiring cardiac mechanical supports. Dr. Foglieni' laboratory has optimized/applied a variety of research tools, i.e. 2D/3D models for vascular tissue culture and cell biology; techniques for histology, confocal/electron microscopy; methods for protein biochemistry and molecular biology (mRNAs and noncoding RNAs); and for ex vivo imaging. Collaboration with The Scripps Research Institute in CA led to the optimization of a system for quantifying of tissue thrombogenicity. Thanks to ongoing research agreement with PoliMi, her team provides biological setup of in vitro functional models in technologically advanced bioreactors, contributing to development of a co-patented system and the creation of a startup, named TTOP technologies S.r.l.